{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:00:41Z","timestamp":1788235241896,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Association Surr\u00e9nales, France"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gastrointestinal symptoms are frequent in acute adrenal insufficiency. Although digestive symptoms can significantly reduce quality of life, they are rarely described in patients with treated chronic adrenal insufficiency (CAI). We aimed to characterize digestive symptoms in CAI patients. We used the section pertaining functional bowel disorders of the Rome IV questionnaire. A questionnaire was published on the website of the non-profit patient association \u201cAdrenals\u201d (NPPA of CAI patients) for five months. Information on demographics, characteristics of adrenal insufficiency, digestive symptoms and quality of life was collected. The relatives of CAI patients served as a control group. We analyzed responses of 33 control subjects and 119 patients (68 primary adrenal insufficiency (PAI), 30 secondary adrenal insufficiency (SAI) and 21 congenital adrenal hyperplasia (CAH)). Abdominal pain at least once a week over the past 3\u00a0months was reported by 40%, 47% and 33% of patients with PAI, SAI and CAH respectively versus 15% for the controls (<jats:italic>p<\/jats:italic>\u2009=\u20090.01). Symptoms were consistent with the Rome IV criteria for irritable bowel syndrome in 27%, 33% and 33% of patients respectively versus 6% for the controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Quality of life was described as poor or very poor in 35%, 57% and 24% of patients respectively versus 5% for the controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). In conclusion, digestive symptoms are frequent and incapacitating in CAI patients and similar to symptoms of irritable bowel syndrome in 30% of CAI patients. Assessment and management of digestive symptoms should be considered a priority for physicians treating patients with CAI.<\/jats:p>","DOI":"10.1038\/s41598-021-87158-2","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T10:05:57Z","timestamp":1618308357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms"],"prefix":"10.1038","volume":"11","author":[{"given":"L.","family":"Qu\u00e9n\u00e9herv\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Drui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Blin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"P\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Coron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Barbaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Neunlist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bach-Ngohou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"issue":"6","key":"87158_CR1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ando.2017.10.010","volume":"78","author":"O Chabre","year":"2017","unstructured":"Chabre, O., Goichot, B., Zenaty, D. & Bertherat, J. Group 1. Epidemiology of primary and secondary adrenal insufficiency: prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality. Ann. Endocrinol. (Paris) 78(6), 490\u2013494 (2017).","journal-title":"Ann. Endocrinol. (Paris)"},{"issue":"2","key":"87158_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1210\/jc.2014-3191","volume":"100","author":"S Hahner","year":"2015","unstructured":"Hahner, S. et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J. Clin. Endocrinol. Metab. 100(2), 407\u2013416 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"87158_CR3","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1056\/NEJMra1807486","volume":"381","author":"RL Rushworth","year":"2019","unstructured":"Rushworth, R. L., Torpy, D. J. & Falhammar, H. Adrenal crisis. N. Engl. J. Med. 381(9), 852\u2013861 (2019).","journal-title":"N. Engl. J. Med."},{"issue":"9372","key":"87158_CR4","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(03)13492-7","volume":"361","author":"W Arlt","year":"2003","unstructured":"Arlt, W. & Allolio, B. Adrenal insufficiency. Lancet 361(9372), 1881\u20131893 (2003).","journal-title":"Lancet"},{"issue":"12","key":"87158_CR5","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1210\/jc.2009-1368","volume":"94","author":"MM Erichsen","year":"2009","unstructured":"Erichsen, M. M. et al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J. Clin. Endocrinol. Metab. 94(12), 4882\u20134890 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"87158_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1210\/jc.2009-1711","volume":"95","author":"K L\u00f8v\u00e5s","year":"2010","unstructured":"L\u00f8v\u00e5s, K. et al. Development of a disease-specific quality of life questionnaire in Addison\u2019s disease. J. Clin. Endocrinol. Metab. 95(2), 545\u2013551 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"87158_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1530\/EJE-08-0578","volume":"159","author":"B Bleicken","year":"2008","unstructured":"Bleicken, B. et al. Impaired subjective health status in chronic adrenal insufficiency: impact of different glucocorticoid replacement regimens. Eur. J. Endocrinol. 159(6), 811\u2013817 (2008).","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"87158_CR8","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1210\/jc.2007-0685","volume":"92","author":"S Hahner","year":"2007","unstructured":"Hahner, S. et al. Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J. Clin. Endocrinol. Metab. 92(10), 3912\u20133922 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"87158_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12020-018-1723-0","volume":"62","author":"E Daae","year":"2018","unstructured":"Daae, E., Feragen, K. B., Nermoen, I. & Falhammar, H. Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review. Endocrine 62(1), 3\u201313 (2018).","journal-title":"Endocrine"},{"key":"87158_CR10","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.psyneuen.2016.06.015","volume":"72","author":"CD Andela","year":"2016","unstructured":"Andela, C. D. et al. Quality of life in patients with adrenal insufficiency correlates stronger with hydrocortisone dosage, than with long-term systemic cortisol levels. Psychoneuroendocrinology 72, 80\u201386 (2016).","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"87158_CR11","first-page":"1302","volume":"84","author":"MV Tobin","year":"1989","unstructured":"Tobin, M. V., Aldridge, S. A., Morris, A. I., Belchetz, P. E. & Gilmore, I. T. Gastrointestinal manifestations of Addison\u2019s disease. Am. J. Gastroenterol. 84(10), 1302\u20131305 (1989).","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"87158_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1096\/fj.15-278309","volume":"30","author":"MA Quinn","year":"2016","unstructured":"Quinn, M. A. & Cidlowski, J. A. Endogenous hepatic glucocorticoid receptor signaling coordinates sex-biased inflammatory gene expression. FASEB J. 30(2), 971\u2013982 (2016).","journal-title":"FASEB J."},{"issue":"2","key":"87158_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/qjmed\/95.2.79","volume":"95","author":"C O\u2019Leary","year":"2002","unstructured":"O\u2019Leary, C. et al. Coeliac disease and autoimmune Addison\u2019s disease: a clinical pitfall. QJM 95(2), 79\u201382 (2002).","journal-title":"QJM"},{"issue":"8","key":"87158_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1136\/gutjnl-2013-305690","volume":"63","author":"T Vanuytsel","year":"2014","unstructured":"Vanuytsel, T. et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut 63(8), 1293\u20131299 (2014).","journal-title":"Gut"},{"issue":"1","key":"87158_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1874467210666170224095741","volume":"11","author":"Y Tache","year":"2018","unstructured":"Tache, Y., Larauche, M., Yuan, P.-Q. & Million, M. Brain and gut CRF signaling: biological actions and role in the gastrointestinal tract. Curr. Mol. Pharmacol. 11(1), 51\u201371 (2018).","journal-title":"Curr. Mol. Pharmacol."},{"key":"87158_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756284820910630","volume":"13","author":"M Casado-Bedmar","year":"2020","unstructured":"Casado-Bedmar, M. & Keita, A. V. Potential neuro-immune therapeutic targets in irritable bowel syndrome. Ther. Adv. Gastroenterol. 13, 1\u201315. https:\/\/doi.org\/10.1177\/1756284820910630 (2020).","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"11","key":"87158_CR17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1177\/1756283X17730748","volume":"10","author":"A Ibrahim","year":"2017","unstructured":"Ibrahim, A. et al. The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothamalic-pituitary-adrenal axis: a retrospective observational study. Ther. Adv. Gastroenterol. 10(11), 829\u2013836. https:\/\/doi.org\/10.1177\/1756283X17730748 (2017).","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"6","key":"87158_CR18","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1517\/17425255.4.6.749","volume":"4","author":"H Lennern\u00e4s","year":"2008","unstructured":"Lennern\u00e4s, H., Skrtic, S. & Johannsson, G. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors. Expert Opin. Drug Metab. Toxicol. 4(6), 749\u2013758 (2008).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"3","key":"87158_CR19","first-page":"241","volume":"59","author":"B Bonaz","year":"2013","unstructured":"Bonaz, B. Inflammatory bowel diseases: a dysfunction of brain\u2013gut interactions?. Minerva Gastroenterol. Dietol. 59(3), 241\u2013259 (2013).","journal-title":"Minerva Gastroenterol. Dietol."},{"issue":"5","key":"87158_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2036.2003.01456.x","volume":"17","author":"APS Hungin","year":"2003","unstructured":"Hungin, A. P. S., Whorwell, P. J., Tack, J. & Mearin, F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment. Pharmacol. Ther. 17(5), 643\u2013650 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"87158_CR21","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/j.1572-0241.2005.40674.x","volume":"100","author":"M Guilera","year":"2005","unstructured":"Guilera, M., Balboa, A. & Mearin, F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am. J. Gastroenterol. 100(5), 1174\u20131184 (2005).","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"87158_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ajg.2012.131","volume":"107","author":"RM Lovell","year":"2012","unstructured":"Lovell, R. M. & Ford, A. C. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am. J. Gastroenterol. 107(7), 991\u20131000 (2012).","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"87158_CR23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1053\/gast.2000.16484","volume":"119","author":"IM Gralnek","year":"2000","unstructured":"Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B. & Mayer, E. A. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119(3), 654\u2013660 (2000).","journal-title":"Gastroenterology"},{"key":"87158_CR24","doi-asserted-by":"crossref","unstructured":"Menees, S. & Chey, W. The gut microbiome and irritable bowel syndrome. F1000Research 2018, 7F(F1000 Faculty Rev), 1029. Last updated: 09 July 2018.","DOI":"10.12688\/f1000research.14592.1"},{"issue":"23","key":"87158_CR25","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.3748\/wjg.15.2834","volume":"15","author":"R Daher","year":"2009","unstructured":"Daher, R., Yazbeck, T., Jaoude, J. B. & Abboud, B. Consequences of dysthyroidism on the digestive tract and viscera. Word J Gastroenterol. 15(23), 2834\u20132838 (2009).","journal-title":"Word J Gastroenterol."},{"issue":"8","key":"87158_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.tem.2019.05.008","volume":"30","author":"E Frohlich","year":"2019","unstructured":"Frohlich, E. & Wahl, R. Microbiota and thyroid interaction in health and disease. Trends Endocrinol. Metab. 30(8), 479\u2013490 (2019).","journal-title":"Trends Endocrinol. Metab."},{"key":"87158_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1756284820977402","volume":"13","author":"S Erdrich","year":"2020","unstructured":"Erdrich, S., Hawrelak, J. A., Myers, S. P. & Harnett, J. E. A systematic review of the association between fibromyalgia and functional gastrointestinal disorders. Ther. Adv. Gastroenterol. 13, 1\u201317 (2020).","journal-title":"Ther. Adv. Gastroenterol."},{"issue":"4","key":"87158_CR28","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1097\/MCG.0000000000000978","volume":"53","author":"R Addante","year":"2019","unstructured":"Addante, R. et al. Predictors of health related quality of life in irritable bowel syndrome patients compared to healthy individuals. J. Clin. Gastroenterol. 53(4), e142\u2013e149 (2019).","journal-title":"J. Clin. Gastroenterol."},{"issue":"26","key":"87158_CR29","doi-asserted-by":"publisher","first-page":"8103","DOI":"10.3748\/wjg.v21.i26.8103","volume":"21","author":"P Singh","year":"2015","unstructured":"Singh, P. et al. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World J. Gastroenterol. 21(26), 8103\u20138109 (2015).","journal-title":"World J. Gastroenterol."},{"key":"87158_CR30","doi-asserted-by":"publisher","unstructured":"Mearin, F., Lacy, B. E., Chang, L., Chey, W. D., Lembo, A. J., Simren, M. et al. Bowel disorders. Gastroenterology S0016\u20135085(16), 00222\u20135. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031 (2016).","DOI":"10.1053\/j.gastro.2016.02.031"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87158-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87158-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87158-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T06:33:06Z","timestamp":1670049186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-87158-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["87158"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-87158-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8077"}}